Aim: To evaluate central retinal thickness and foveal function using optical coherence tomography (OCT) and the Rarebit Fovea Test (RFT) in patients with diabetes without previously known retinopathy or maculopathy. Method: Forty-two patients with diabetes mellitus (DM) were selected from the screening records at St Erik Eye Hospital. Inclusion criteria were absence of macular or other retinal changes at previous screening examination and best corrected visual acuity >1.0. These patients and 42 healthy controls were examined with the recently developed RFT, and retinal thickness was measured using OCT. Lens thickness and light scatter were evaluated by Scheimpflug photography. Results: Significantly more DM subjects (12/42) had a subnormal RFT result compared with the controls (2/42) (p = 0.007). None of the 12 DM subjects had maculopathy, one had mild non proliferative diabetic retinopathy, and five had minimal non-proliferative diabetic retinopathy. The retinal thickness in the pericentral zone was significantly (p,0.05) thinner in DM patients with subnormal RFT compared with the controls. Conclusion: Decreased RT and subnormal RFT results were found in a subgroup of diabetes patients, despite normal screening results. Prospective studies are under way to evaluate the prognostic implications. S tandard procedures for diabetes mellitus (DM) screening are fundus photography or funduscopy with dilated pupils. However, there is evidence suggesting that neuronal changes have an important role in the development of diabetic retinopathy (DRP) and that retinal degeneration may precede visible or vascular changes.
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MATERIALS AND METHODS

Forty
The RFT test is included in the Rarebit Perimetry program package 4 (see http://www.oft.gu.se/webdiagnos/) and runs on a personal computer with a liquid crystal display. The test principle is to briefly (200 ms) present zero, one or two bright and very small (,0.5 min of arc) dots against a dark background in a completely dark room. The test task is to fixate a small, flickering cross in the middle of the screen and to respond by one or two mouse clicks when one or two test stimuli are detected anywhere on the screen. The test time is approximately 90 s, and the result is presented as mean hit rate (MHR), that is the number of stimuli seen relative to stimuli presented ( fig 1) . Based on data from a previous study, 5 the stimulus luminance was set to 68 cd/m 2 , expected to give a MHR close to 100%, that is 97% or better, in normal subjects.
High-resolution fundus photographs were obtained with dilated pupils, using a Zeiss FF450 plus IRu TM (Jena DE) fundus camera. The Visupac 3.5 Software TM (Pirmasens, DE) was used for analysing the images. The severity of DRP and diabetic maculopathy was classified by one of the authors (GvW), based on the criteria of the ETDRS protocol. 6 Lens thickness and light scatter were evaluated by Scheimpflug photography, using the Nidek, EAS-1000 TM (Nidek Inc), after pupil dilation. The distance from the anterior lens capsule to the central clear zone (zone A-E) was used as a measure of lens thickness. 7 The lens light scatter was measured in the anterior adult nuclear area, including a part of the deep cortical layer, since it is assumed that this layer should have the largest influence on the overall optical quality of the lens. 7 The macular thickness was measured with optical coherence tomography using the Stratus OCT TM , model 3000 (Carl Zeiss Meditec Int.) with a dilated pupil. Six radial OCT scans were obtained in the centre of the macula. For analysis of the RT, the macula was divided into three areas: the fovea with a diameter of 1 mm, the pericentral area (doughnut-shaped ring with an inner diameter of 1 mm and an outer of 3 mm) and the peripheral area (inner diameter of 3 mm and an outer of 6 mm). Both eyes in all subjects were examined in random order, and the results from right eyes were used for analysis.
The study was approved by the local ethical committee and performed according to the Helsinki declaration. Written informed consent was obtained from all participants.
For statistical analysis, the Student t test, a one-way ANOVA test and the Fisher test were used. A p value of ,0.05 was regarded as significant. 
RESULTS
There was a significant (p = 0.03) difference between the groups regarding MHR; the mean MHR for the DM group was 96 (9)% and for controls 99 (2)%. Also, significantly more subjects with DM (12/42) had a subnormal RFT (,97%) compared with the controls (2/42) (p = 0.007; see fig 2) . None of the 12 DM subjects with abnormal RFT had maculopathy, one had mild non-proliferative diabetic retinopathy, and five had minimal non-proliferative diabetic retinopathy. The retinal thickness measured in the pericentral zone was significantly (p,0.05) thinner in DM subjects with subnormal MHR compared with controls (see table 2), but there was no significant correlation between RFT findings and OCT measurements.
One of the two controls with subnormal RFT (MHR = 91%) had drusen. In the other subject (MHR = 96%) no ocular abnormalities were detected. Among the subjects with normal RFT results, 14 of the 42 controls had drusen or age-related pigment epithelial defects, and one subject with DM was classified as having a mild maculopathy and four had drusen. None of the studied parameters showed any correlation with age, duration or type of DM.
Analysis of the Scheimpflug images revealed no significant difference between the DM group and the control group regarding lens light scatter and thickness, and these data are not further reported here.
DISCUSSION
The current study reports reduced RFT mean hit rate in a subgroup of patients with DM with no or mild retinopathy. This observation supports the RFT concept, that is detection of lowdegree neural damage. 4 The test principle, with very small stimuli, is assumed to test the integrity of the retino-cortical detector matrix, in the fovea defined by photoreceptor density. The signal from these receptors is relayed through the Henle loops to the perifoveal ganglion cells, stacked on top of each other. 8 The demonstration by OCT that the pericentral retinal area is significantly thinner in the DM patients is in agreement with findings by Biallosterski and co-workers, 3 and confirms the relevance of the RFT results. These signs of neural degeneration can be present without visible vascular changes, since the fundus photographs did not show any abnormalities in 6 of the 12 subjects with subnormal RFT results. This observation is in line with recent findings in studies of retinal changes in DM using histology, electrophysiology and nervefibre layer imaging. 2 9 10 The reverse finding, normal RFT and mild maculopathy was observed in only one DM subject. In none of the patients with diabetes was fluorescein angiography considered to be indicated. Fundus photography revealed nondiabetic abnormalities in almost 30% of healthy controls. Hard drusen are common in subject above 40 years of age 11 and are, as an isolated finding, not regarded as a sign of macular degeneration. 12 The RFT is designed to detect small defects in the retinocortical detector layer, which is assumed to normally be complete. To achieve this, the test target should, in theory, stimulate only one receptive field. Owing to the very high cone density in the Figure 1 RFT results from one control and one diabetic subject. Empty squares indicate that all dots have been perceived within the test area. The fraction of missed targets is proportionally depicted by a grey scale in the test area. In the example from a normal subject to the left, only one dot was missed in one area, and the mean hit rate was 99%. In the example to the right, from a diabetic subject, the mean hit rate was 54%. fovea, this is a technical challenge. 13 14 Makous and co-workers 15 recently used adaptive optics and microflashes in a study of a subject with genetically determined absence of green-sensitive cones. With a small bright stimulus, subtending 0.759 and with the use of adaptive optics to minimise the influence of the aberrations of the eye's optical system, they managed to detect scotomas as small as the size of one photoreceptor. The results of this and the present study indicate that psychophysical techniques, using very small stimuli, may be a useful method for the detection of very small defects in the fovea.
CONCLUSION
Macular changes, not detected by screening methods, could be demonstrated using both structural and functional tests in a subgroup of patients with DM with no or minimal retinopathy. Prospective studies are under way to evaluate the prognostic implications of these observations. 
